Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward (2021) Krug D, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P, Fietkau R, et al. Journal article, Review article Prospective evaluation of multitarget treatment of pediatric patients with helical intensity-modulated radiotherapy (2020) Salfelder MEA, Kessel KA, Thiel U, Burdach S, Kampfer S, Combs SE Journal article Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy (2020) Nicosia L, Cuccia F, Mazzola R, Ricchetti F, Figlia V, Giaj-Levra N, Rigo M, et al. Journal article Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients (2020) Muench S, Marr L, Feuerecker B, Dapper H, Braren R, Combs SE, Duma MN Journal article Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer (2020) Borm KJ, Oechsner M, Duesberg M, Buschner G, Wolfgang W, Combs SE, Duma MN Journal article Stereotactic or intensity modulated Radiotherapy of adrenal Metastases - Patient Characteristics and Therapy Results of a multicenter Analysis (2020) Buergy D, Wuerschmidt F, Gkika E, Hoerner-Rieber J, Knippen S, Gerum S, Balermpas P, et al. Conference contribution Dose Escalation and local Control after stereotactic Radiotherapy of adrenal Metastases of the Non-Small Cell Lung Carcinoma (NSCLC) - A multicenter Analysis (2020) Buergy D, Wurschmidt F, Hoerner-Rieber J, Gkika E, Knippen S, Gerum S, Balermpas P, et al. Conference contribution Reviewer and Publication Behavior in Radiation Therapy/Radiation Biology / Medical Physics in Germany, Austria and Switzerland - an Online Survey by jDEGRO (2020) Kaesmann L, Baasse A, Frey B, Fleischmann D, Gauer T, Ebert N, Hecht M, et al. Conference contribution Analysis of antioxidant Factors in Patients' Blood with chronic Degenerative and inflammatory Diseases in the Course of Low-Dose Radiotherapy (2020) Hehlgans S, Donaubauer AJ, Becker I, Frey B, Oppermann J, Ott O, Weissmann T, et al. Conference contribution Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution